title: Active efflux kinetics of etoposide from rabbit small intestine and colon.
abstract: The aim of the present study was to investigate the directional transport kinetics of etoposide in rabbit intestinal tissues using side-by-side diffusion chambers. Etoposide is a routinely used mixed-mechanism 'efflux' inhibitor; however, its absorptive and secretory transport kinetics in rabbit intestinal tissues, a commonly used animal model, have not yet been reported. Kinetic studies revealed that the apical (AP) to basolateral (BL) (i.e. absorptive) transport of etoposide was not apparently mediated by specialized transporters, whereas secretion (i.e. BL to AP transport) by intestinal tissues was concentration dependent and saturable. Half-saturation constant values (K(m), mean+/-standard deviation (S.D.)) ranged from 53.6+/-35.8 microM to 168.7+/-127.3 microM, consistent with previous results from our group in intestinal tissues from other species and Caco-2 cell monolayers. Secretory permeability was greatest in the ileum, whereas values in the upper small intestine and colon were approximately equal, and represented only 50% of the value in the ileum. The ileal secretory transport of etoposide was temperature dependent, with the activation energy (E(a)) >4 kCal/mole at 5 microM, suggesting the involvement of the active, energy dependent mechanism. Etoposide inhibition by verapamil and saquinavir, known inhibitors of intestinal secretion, was characterized as competitive with K(i)'s equal to 193.0+/-164.4 microM and 72.6+/-53.5 microM, respectively. The current results demonstrate that the absorptive transport of etoposide in rabbit tissue was not mediated by specialized carriers, and that secretory transport was regionally dependent, mediated by a transporter or transporters, the K(m)'s were in the micromolar range, and involved the energy dependent mechanism(s). The relatively low k(m) of etoposide compared with its aqueous solubility (0.25-0.34 mM, pH 5-6.5, 25 degrees C) makes it the excellent mixed-mechanism competitive inhibitor for determining the secretory transport properties of putative drug substrates. Understanding the in vitro secretory transport kinetics of etoposide provides a mechanistic basis for ongoing studies exploring the functional role of 'efflux' in vivo.
authors: Department of Pharmaceutics, College of Pharmacy, Rutgers University, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA.
authors: J
authors: J
authors: Kunta
authors: J
authors: J
authors: Yan
authors: V D
authors: VD
authors: Makhey
authors: P J
authors: PJ
authors: Sinko
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000502:physiology; D000818:Animals; D027321:Anion Transport Proteins; D000972:Antineoplastic Agents, Phytogenic / Q000493:pharmacokinetics*; D001692:Biological Transport; D002352:Carrier Proteins / Q000502:physiology; D003106:Colon / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005047:Etoposide / Q000493:pharmacokinetics*; D005260:Female; D007421:Intestine, Small / Q000378:metabolism*; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D011817:Rabbits; D013696:Temperature
chemical_list: D018528:ATP-Binding Cassette Transporters; D027321:Anion Transport Proteins; D000972:Antineoplastic Agents, Phytogenic; D002352:Carrier Proteins; D005047:Etoposide; D027425:ATP-Binding Cassette, Sub-Family C Proteins